Top
Search
Downloads
Faq
About
Note:
You're navigating the results of models obtained with the previous release of
IntOGen (2020)
. A new boostDM version corresponding to the current IntOGen release will be available soon.
TP53
17:7675056:T (D186N)
×
Driver potential
Paste this link in an email or IM
×
Model
BoostDM class
BoostDM score
(AML) Acute myeloid leukemia
Passenger
0.13
(BLCA) Bladder cancer
Passenger
0.00
(BRCA) Breast adenocarcinoma
Passenger
0.00
(CH) Cholangiocarcinoma
Passenger
0.06
(CLL) Chronic lymphoblastic leukemia
Driver
0.62
(CM) Cutaneous melanoma of the skin
Passenger
0.00
(COREAD) Colorectal adenocarcinoma
Passenger
0.00
(DLBCL) Diffuse large B-cell lymphoma
Passenger
0.48
(ESCA) Esophageal cancer
Passenger
0.00
(GBM) Glioblastoma
Passenger
0.05
(HC) Hepatic cancer
Passenger
0.00
(HGG) High-grade glioma
Passenger
0.18
(HNSC) Head and neck squamous cell carcinoma
Passenger
0.00
(LEIS) Leiomyosarcoma
Passenger
0.03
(LGG) Lower grade glioma
Passenger
0.00
(LUAD) Lung adenocarcinoma
Passenger
0.00
(LUNG_CANCER) Lung cancer
Passenger
0.00
(LUSC) Lung squamous cell carcinoma
Passenger
0.00
(LY) Lymphoma
Passenger
0.16
(MM) Multiple myeloma
Passenger
0.03
(NHLY) Non-hodking lymphoma
Passenger
0.23
(OS) Osteosarcoma
Passenger
0.45
(OV) Ovary cancer
Passenger
0.00
(PAAD) Pancreas adenocarcinoma
Passenger
0.00
(PIA) Pilocityc astrocytoma
Driver
0.83
(PRAD) Prostate adenocarcinoma
Passenger
0.00
(R) Kidney cancer
Passenger
0.00
(RCCC) Renal clear cell carcinoma
Passenger
0.00
(RCH) Chromophobe renal cell carcinoma
Passenger
0.00
(S) Sarcoma
Passenger
0.03
(SCLC) Small-cell lung cancer
Passenger
0.00
(ST) Stomach adenocarcinoma
Passenger
0.00
(UCEC) Endometrial cancer
Passenger
0.01
(UCS) Uterine carcinosarcoma
Passenger
0.17
Select a tumor type to check the corresponding model
Show the legend
Predictions cast with a model trained in this specific tumor type.
Predictions cast with a model trained with a more general tumor type, determined as the most recent
underlined
ancestor of the leaf.
Driver
The mutation is predicted to be a driver in this tumor type context.
Passenger
The mutation is predicted to be a passenger in this tumor type context.
Paste this link in an email or IM
×
(CANCER) Cancer
(SOLID) Solid tumour
(S) Sarcoma
(UCS) Uterine carcinosarcoma
Passenger
(OS) Osteosarcoma
Passenger
(LEIS) Leiomyosarcoma
Passenger
(UCEC) Endometrial cancer
Passenger
(ST) Stomach adenocarcinoma
Passenger
(LUNG_CANCER) Lung cancer
(SCLC) Small-cell lung cancer
Passenger
(NSCLC) Non-small cell lung cancer
(LUSC) Lung squamous cell carcinoma
Passenger
(LUAD) Lung adenocarcinoma
Passenger
(R) Kidney cancer
(RCH) Chromophobe renal cell carcinoma
Passenger
(RCCC) Renal clear cell carcinoma
Passenger
(PRAD) Prostate adenocarcinoma
Passenger
(CNS) Central nervous system cancer
(G) Glioma
(PIA) Pilocityc astrocytoma
Driver
(LGG) Lower grade glioma
Passenger
(HGG) High-grade glioma
Passenger
(GBM) Glioblastoma
Passenger
(PA) Pancreatic cancer
(PAAD) Pancreas adenocarcinoma
Passenger
(OV) Ovary cancer
Passenger
(HNSC) Head and neck squamous cell carcinoma
Passenger
(LIVER) LIVER
(HC) Hepatic cancer
Passenger
(ESCA) Esophageal cancer
Passenger
(COREAD) Colorectal adenocarcinoma
Passenger
(SKIN) Skin cancer
(CM) Cutaneous melanoma of the skin
Passenger
(CH) Cholangiocarcinoma
Passenger
(BRCA) Breast adenocarcinoma
Passenger
(BLCA) Bladder cancer
Passenger
(NON_SOLID) Non-Solid cancer
(L) Lymphoid cancer
(LY) Lymphoma
(NHLY) Non-hodking lymphoma
Passenger
(DLBCL) Diffuse large B-cell lymphoma
Passenger
(LK) Leukemia
(CLL) Chronic lymphoblastic leukemia
Driver
(AML) Acute myeloid leukemia
Passenger
(MM) Multiple myeloma
Passenger